1. Home
  2. GLBS vs XLO Comparison

GLBS vs XLO Comparison

Compare GLBS & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globus Maritime Limited

GLBS

Globus Maritime Limited

N/A

Current Price

$1.71

Market Cap

35.0M

ML Signal

N/A

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$0.66

Market Cap

41.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLBS
XLO
Founded
2006
2016
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.0M
41.8M
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
GLBS
XLO
Price
$1.71
$0.66
Analyst Decision
Strong Buy
Buy
Analyst Count
1
1
Target Price
$3.00
$2.00
AVG Volume (30 Days)
363.8K
510.6K
Earning Date
11-28-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$39,444,000.00
$31,804,000.00
Revenue This Year
$24.03
$626.78
Revenue Next Year
$13.92
$79.08
P/E Ratio
N/A
N/A
Revenue Growth
18.49
588.40
52 Week Low
$0.99
$0.62
52 Week High
$1.99
$1.70

Technical Indicators

Market Signals
Indicator
GLBS
XLO
Relative Strength Index (RSI) 62.89 39.03
Support Level $1.65 $0.65
Resistance Level $1.78 $0.68
Average True Range (ATR) 0.13 0.03
MACD -0.00 0.00
Stochastic Oscillator 56.03 31.73

Price Performance

Historical Comparison
GLBS
XLO

About GLBS Globus Maritime Limited

Globus Maritime Ltd is a dry bulk shipping company that provides marine transportation services internationally. The company owns, operates, and manages a fleet of dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina, and other dry bulk cargo. Its operations are managed by its subsidiary which also provides in-house commercial and technical management for its vessels and also offers consulting services for an affiliated ship management company. It generates maximum revenues by charging customers for the use of vessels to transport dry bulk commodities.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.

Share on Social Networks: